# A DB Randomized Study of R1 and R2 WaterJel / AloeVera Jell in Prevention of Radiation Dermatitis in Breast Cancer

> **NCT01597921** · — · TERMINATED · sponsor: **Water-Jel** · enrollment: 50 (actual)

## Conditions studied

- Breast Cancer
- Radiation Dermatitis
- Erythema

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01597921
- **Lead sponsor:** Water-Jel
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2012-05
- **Primary completion:** 2012-12
- **Final completion:** 2012-12
- **Target enrollment:** 50 (ACTUAL)
- **Why stopped:** The study was stopped due to unbalanced side effects
- **Last updated:** 2012-08-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01597921

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01597921, "A DB Randomized Study of R1 and R2 WaterJel / AloeVera Jell in Prevention of Radiation Dermatitis in Breast Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01597921. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*